Target intelligence / Profile preview

Immunoglobulin heavy variable 40-1 (IGHV40-1)

Target
IGHV40-1
Molecular classification
Immunoglobulin gene segment, Immunoglobulin variable domain, Member of the immunoglobulin superfamily (IgSF)
01

Overview

Immunoglobulin heavy variable 40-1 (IGHV40-1) is a gene segment that encodes part of the variable domain of the heavy chain in antibodies (immunoglobulins), which are key mediators of the adaptive immune system. The variable region, formed by combinatorial rearrangement of V (variable), D (diversity), and J (joining) gene segments in B cells, is essential for generating the diverse antigen-binding specificity of antibodies. This diversity enables the immune system to recognize and defend against a vast array of pathogens[2][3][5]. IGHV40-1 contributes to the antigen recognition site but is not a therapeutic target itself—antibody drugs are generated from whole immunoglobulins and not by directly modulating individual variable gene segments. Key clarification: - The term "IGHVII-40-1" is non-standard and should be replaced by "IGHV40-1". - Variable gene segments (like IGHV40-1) encode part of the antibody antigen-binding site but are not themselves drug targets, receptors, or enzymes[2][3][5]. - No structured information about drugs, mechanisms of action, or biomarker status applies to this segment, since those refer to proteins/products (antibodies) formed from many such segments.

Other names
IGHV40-1Immunoglobulin heavy chain variable region 40-1Immunoglobulin heavy variable 40-1
02

Mechanism of action

None (not a direct therapeutic target; no drugs act on IGHV segments)

03

Biological functions

Antigen recognitionGeneration of antibody diversityHumoral immune response
04

Disease associations

Other (gene segments are not directly implicated in specific diseases, but mutations or rearrangements may rarely be linked to lymphoid malignancies)

Beyond the preview

Go deeper on Immunoglobulin heavy variable 40-1 (IGHV40-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable 40-1 (IGHV40-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call